Holocene Advisors, LP Intra Cellular Therapies, Inc. Transaction History

Holocene Advisors, LP

  • $22.9 Billion
  • Q3 2024

A detailed history of Holocene Advisors, LP transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Holocene Advisors, LP holds 1,370,831 shares of ITCI stock, worth $117 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares
1,370,831
Previous 1,479,675 7.36%
Holding current value
$117 Million
Previous $101 Million 1.09%
% of portfolio
0.44%
Previous 0.45%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$67.99 - $80.84 $7.4 Million - $8.8 Million
-108,844 Reduced 7.36%
1,370,831 $100 Million
Q2 2024

Aug 14, 2024
BUY
$64.76 - $79.84 $37 Million - $45.6 Million
570,585 Added 62.76%
1,479,675 $101 Million
Q1 2024

May 15, 2024
SELL
$64.37 - $75.65 $22.7 Million - $26.7 Million
-352,767 Reduced 27.96%
909,090 $62.9 Million
Q4 2023

Feb 14, 2024
SELL
$46.37 - $73.65 $7.91 Million - $12.6 Million
-170,659 Reduced 11.91%
1,261,857 $90.4 Million
Q3 2023

Nov 14, 2023
SELL
$52.09 - $64.1 $13.7 Million - $16.9 Million
-263,292 Reduced 15.53%
1,432,516 $74.6 Million
Q2 2023

Aug 14, 2023
BUY
$54.67 - $66.44 $31.7 Million - $38.5 Million
579,544 Added 51.92%
1,695,808 $107 Million
Q1 2023

May 15, 2023
SELL
$43.8 - $56.99 $26.9 Million - $35 Million
-614,829 Reduced 35.52%
1,116,264 $60.4 Million
Q4 2022

Feb 14, 2023
BUY
$44.07 - $54.45 $6.16 Million - $7.61 Million
139,710 Added 8.78%
1,731,093 $91.6 Million
Q3 2022

Nov 14, 2022
SELL
$42.7 - $59.99 $1.54 Million - $2.16 Million
-36,025 Reduced 2.21%
1,591,383 $74 Million
Q2 2022

Aug 15, 2022
BUY
$43.0 - $65.64 $38.9 Million - $59.4 Million
904,684 Added 125.18%
1,627,408 $92.9 Million
Q1 2022

May 16, 2022
BUY
$38.74 - $62.09 $28 Million - $44.9 Million
722,724 New
722,724 $44.2 Million

Others Institutions Holding ITCI

# of Institutions
378
Shares Held
84.7M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $8.03B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Holocene Advisors, LP Portfolio

Follow Holocene Advisors, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Holocene Advisors, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email